-
1دورية أكاديمية
المؤلفون: Paré, L. (L.), Pascual, T. (T.), Seguí, E. (E.), Teixidó, C. (Cristina), Gonzalez-Cao, M. (María), Galván, P. (P.), Rodríguez, A. (A.), González, B. (B.), Cuatrecasas, M. (M.), Pineda, E. (E.), Torné, A. (A.), Crespo, G. (Guillermo), Martin-Algarra, S. (Salvador), Perez-Ruiz, E. (Elisabeth), Reig, Ó. (Ó.), Viladot, M. (M.), Font, C. (C.), Adamo, B. (B.), Vidal, M. (M.), Gaba, L. (L.), Muñoz, M. (M.), Victoria, I. (I.), Ruiz, G. (G.), Viñolas, N. (N.), Mellado, B. (B.), Maurel, J. (J.), Garcia-Corbacho, J. (J.), Molina-Vila, M.A. (Miguel Angel), Juan, M. (Manel), Llovet, J.M. (J. M.), Reguart, N. (Noemi), Arance, A. (Ana), Prat, A. (A.)
مصطلحات موضوعية: PD1, Gene expression, Anti-PD1, Immunotherapy, Solid tumors
وصف الملف: application/pdf
العلاقة: info:eu-repo/grantAgreement/MINECO/Proyectos de investigación en salud (Modalidad Proyectos de investigación en salud) (AE Salud 2016)/PI16/00904/ES/DOBLE BLOQUE HER2 SIN QUIMIOTERAPIA EN CÁNCER DE MAMA PRECOZ HER2+; https://hdl.handle.net/10171/65644Test
-
2دورية أكاديمية
المؤلفون: Prat, A., Pascual, T., De Angelis, C., Gutierrez, C., Llombart-Cussac, A., Wang, T., Cortés, J., Rexer, B., Paré, L., Forero, A., Wolff, A.C., Morales, S., Adamo, B., Brasó-Maristany, F., Vidal, M., Veeraraghavan, J., Krop, I., Galván, P., Pavlick, A.C., Bermejo, B., Izquierdo, M., Rodrik-Outmezguine, V., Reis-Filho, J.S., Hilsenbeck, S.G., Oliveira, M., DIeci, M.V., Griguolo, G., Fasani, R., Nuciforo, P., Parker, J.S., Conte, P., Schiff, R., Guarneri, V., Osborne, C.K., Rimawi, M.F.
المصدر: Journal of the National Cancer Institute, 112(1)
مصطلحات موضوعية: Neoadjuvant Therapy, Treatment Outcome, Lapatinib, Aged, Female, Humans, Middle Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Antineoplastic Agents, Molecular Targeted Therapy, Clinical Trials, Phase III as Topic, Prognosis, Receptor, ErbB-2, Antibodies, Monoclonal, Humanized, Biomarkers, Tumor, Adult, Reproducibility of Results, Gene Expression, Neoplasm Staging, Survival Analysis, Phase II as Topic
العلاقة: https://doi.org/10.17615/ccpq-0s57Test; https://cdr.lib.unc.edu/downloads/4b29bf32z?file=thumbnailTest; https://cdr.lib.unc.edu/downloads/4b29bf32zTest
الإتاحة: https://doi.org/10.17615/ccpq-0s57Test
https://cdr.lib.unc.edu/downloads/4b29bf32z?file=thumbnailTest
https://cdr.lib.unc.edu/downloads/4b29bf32zTest -
3دورية أكاديمية
المؤلفون: Karginova, O., Siegel, M. B., Van Swearingen, A. E. D., Deal, A. M., Adamo, B., Sambade, M. J., Bazyar, S., Nikolaishvili-Feinberg, N., Bash, R., O'Neal, S., Sandison, K., Parker, J. S., Santos, C., Darr, D., Zamboni, W., Lee, Y. Z., Miller, C. R., Anders, C. K.
المصدر: Molecular Cancer Therapeutics, 14(4)
مصطلحات موضوعية: H2afx, Mutation, Neoplasm Metastasis, Mus musculus, Brain, Apoptosis, PARP1, Carboplatin, Casp3, Gene Expression, Claudins, Triple Negative Breast Neoplasms, Neoplasms, Caspase 3, Proteins, Sensitivity and Specificity, Penetrance, Cells, DNA Repair, Platinum, Breast, DNA Damage, Therapeutics, Prognosis, Brain Neoplasms, Nprl3
العلاقة: https://doi.org/10.17615/jy3y-pj77Test; https://cdr.lib.unc.edu/downloads/k643b839d?file=thumbnailTest; https://cdr.lib.unc.edu/downloads/k643b839dTest
الإتاحة: https://doi.org/10.17615/jy3y-pj77Test
https://cdr.lib.unc.edu/downloads/k643b839d?file=thumbnailTest
https://cdr.lib.unc.edu/downloads/k643b839dTest -
4دورية أكاديمية
المؤلفون: Prat, A, Lluch, A, Albanell, J, Barry, W T, Fan, C, Chacón, J I, Parker, J S, Calvo, L, Plazaola, A, Arcusa, A, Seguí-Palmer, M A, Burgues, O, Ribelles, N, Rodriguez-Lescure, A, Guerrero, A, Ruiz-Borrego, M, Munarriz, B, López, J A, Adamo, B, Cheang, M C U
المصدر: British Journal of Cancer; 10/14/2014, Vol. 111 Issue 8, p1532-1541, 10p, 1 Chart, 4 Graphs
مصطلحات موضوعية: TRIPLE-negative breast cancer, BREAST cancer treatment, CANCER chemotherapy, GENE expression, POLYMERASE chain reaction, CLINICAL trials
-
5
المؤلفون: Miguel Martín, Laia Paré, Barbara Adamo, Roberta Fasani, Blanca Gonzalez-Farre, Benedetta Conte, Giovanna Sabarese, Carlos H. Barrios, Fara Brasó-Maristany, Esther Sanfeliu, Mariavittoria Locci, Giuseppe Perrone, Francesca Zalfa, Esther Barnadas, Olga Martínez-Sáez, Aranzazu Fernandez-Martinez, Ana Lluch, Maria Vidal, Joaquín Gavilá, Tomás Pascual, Aleix Prat, Francesco Schettini, Sabino De Placido, Patricia Villagrasa, Vicente Peg, Nuria Chic, Juan Miguel Cejalvo
المساهمون: Schettini, F., Chic, N., Braso-Maristany, F., Pare, L., Pascual, T., Conte, B., Martinez-Saez, O., Adamo, B., Vidal, M., Barnadas, E., Fernandez-Martinez, A., Gonzalez-Farre, B., Sanfeliu, E., Cejalvo, J. M., Perrone, G., Sabarese, G., Zalfa, F., Peg, V., Fasani, R., Villagrasa, P., Gavila, J., Barrios, C. H., Lluch, A., Martin, M., Locci, M., De Placido, S., Prat, A., Institut Català de la Salut, [Schettini F] Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. [Chic N] Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. [Brasó-Maristany F] Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. [Paré L] SOLTI Breast Cancer Research Group, Barcelona, Spain. [Pascual T] Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. Department of Genetics, University of North Carolina, Chapel Hill, NC, USA. [Conte B] Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. Department of Medical Oncology, Ospedale Policlinico San Martino, University of Genova, Genova, Italy. [Peg V] Vall d’Hebron Hospital Universitari, Barcelona, Spain. GEICAM, Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain. [Fasani R] Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
Scientia
NPJ Breast Cancer
npj Breast Cancer, Vol 7, Iss 1, Pp 1-13 (2021)مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], Disease, Article, Càncer de mama, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Mama - Càncer, Internal medicine, Gene expression, Cancer genomics, Other subheadings::Other subheadings::/genetics [Other subheadings], Medicine, High activity, Pharmacology (medical), Radiology, Nuclear Medicine and imaging, skin and connective tissue diseases, Gene, Pathological, neoplasms, RC254-282, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Her2 expression, business.industry, Otros calificadores::Otros calificadores::/genética [Otros calificadores], Investigative Techniques::Genetic Techniques::Gene Expression Profiling [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Translational research, medicine.disease, Expressió gènica, 3. Good health, ERBB2 Amplification, técnicas de investigación::técnicas genéticas::perfiles de expresión génica [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], 030104 developmental biology, 030220 oncology & carcinogenesis, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c10b99479fa39b069aa421ecf890520Test
http://hdl.handle.net/2445/175264Test -
6دورية أكاديمية
المؤلفون: Giuffrè, G.1, Adamo, V.2, Ieni, A.1, Colonese, F.2, Barresi, V.1, Caristi, N.2, Adamo, B.2, Tuccari, G.1 tuccari@unime.it
المصدر: Pathology - Research & Practice. Aug2011, Vol. 207 Issue 8, p487-491. 5p.
مصطلحات موضوعية: *HEMATOPOIETIC stem cells, *BREAST cancer, *IMMUNOHISTOCHEMISTRY, *LYMPH nodes, *VASCULAR endothelial growth factors, *DISEASE progression, *GENE expression, *MULTIVARIATE analysis
-
7دورية أكاديمية
المؤلفون: Chic, N.1 (AUTHOR), Pascual, T.1 (AUTHOR), Brasó-Maristany, F.2 (AUTHOR), Villagrasa Gonzalez, P.3 (AUTHOR), Pare Brunet, L.3 (AUTHOR), Schettini, F.4 (AUTHOR), Conte, B.5 (AUTHOR), Adamo, B.6 (AUTHOR), Vidal, M.6 (AUTHOR), Muñoz, M.6 (AUTHOR), Martínez, O.6 (AUTHOR), Gonzalez-Farre, B.7 (AUTHOR), Cortés, J.8 (AUTHOR), Llombart-Cussac, A.9 (AUTHOR), Rodrik-Outmezguine, V.10 (AUTHOR), Izquierdo Delso, M.A.11 (AUTHOR), Schiff, R.12 (AUTHOR), Osborne, C.K.13 (AUTHOR), Rimawi, M.13 (AUTHOR), Prat, A.14 (AUTHOR)
المصدر: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv36-v37. 2p.
مصطلحات موضوعية: *HORMONE receptor positive breast cancer, *METASTATIC breast cancer, *GENE expression, *HORMONE therapy, *SURVIVAL rate, *EXPERT evidence
الشركة/الكيان: NOVARTIS AG 001221845 NVS, DAIICHI Sankyo Inc.
-
8دورية أكاديمية
المؤلفون: Schettini, F.1, Chic, N.2, Brasó-Maristany, F.1, Paré, L.3, Pascual, T.4, Conte, B.5, Martínez-Sáez, O.6, Adamo, B.6, Vidal, M.2, Fernandez-Martinez, A.7, González-Farré, B.8, Sanfeliu, E.8, Perrone, G.9, Villagrasa, P.3, Gavila Gregori, J.10, Barrios, C.H.11, Lluch, A.12, Martin Jimenez, M.13, De Placido, S.14, Prat, A.15
المصدر: Annals of Oncology. 2020 Supplement 2, Vol. 31, pS24-S24. 1p.
مصطلحات موضوعية: *BREAST cancer, *GENE expression, *ANTIBODY-drug conjugates, *PROTEIN expression, *HORMONE receptors, *MESSENGER RNA
-
9دورية أكاديمية
المؤلفون: Mallafré-Larrosa, M.1 (AUTHOR), Pascual, T.1 (AUTHOR), Chic, N.2 (AUTHOR), Martínez, O.2 (AUTHOR), Galvan, P.1 (AUTHOR), Gonzalez-Farre, B.3 (AUTHOR), Vidal, M.2 (AUTHOR), Muñoz, M.2 (AUTHOR), Adamo, B.2 (AUTHOR), Prat, A.2 (AUTHOR)
المصدر: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv111-v111. 1p.
مصطلحات موضوعية: *GENE expression, *OVERALL survival, *PROGRESSION-free survival, *MEDICAL research, *EXPERT evidence, *TUMOR classification
مصطلحات جغرافية: BARCELONA (Spain)
الشركة/الكيان: DAIICHI Sankyo Inc. , NOVARTIS AG 001221845 NVS
-
10
المؤلفون: Lourdes Calvo, Brandy Pitcher, Chun-Yang Fan, Álvaro Rodríguez-Lescure, Lisa A. Carey, Blanca Munárriz, William T. Barry, Eric P. Winer, Eva Carrasco, Marc L. Citron, Aleix Prat, Nuria Ribelles, Maggie C.U. Cheang, Elaine R. Mardis, MC Liu, Manuel Ruiz-Borrego, Jose Ignacio Chacon, A. Arcusa, Rafael Caballero, Joan Albanell, E. Alba, Tammi L. Vickery, Matthew J. Ellis, Joel S. Parker, A. Lluch, Clifford A. Hudis, Yufeng Li, Miguel Angel Seguí-Palmer, Ángel L Guerrero, Barbara Adamo, Arrate Plazaola, Margaret L. Gulley, Miguel Martin, Octavio Burgues, José A. López, Maria Vidal, Zhiyuan Hu, Charles M. Perou
المساهمون: Universitat de Barcelona, [Prat,A, Adamo,B, Vidal,M.J] Translational Genomics Group, Vall D'Hebron Institute of Oncology (VHIO) Barcelona, Spain. [Prat,A] Department of Medicine, Universitat Autònoma de Barcelona, Spain. [Lluch,A, Burgues,O] Department of Medical Oncology, Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. [Albanell,J] Department of Medical Oncology, Hospital Del Mar, IMIM, Barcelona, Spain. [Albanell,J] Department of Medical Oncology, Universitat Pompeu Fabra (UPF), Barcelona, Spain. [Barry,W.T] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, United States. [Fan,C, Parker,J.S, Cheang,M.C.U, Li,Y, Hu,Z, Gulley,M.L, Carey,L.A, Perou,C.M] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States. [Chacón,J.I] Department of Medical Oncology, Hospital Virgen de la Salud, Toledo, Spain. [Parker,J.S, Perou,C.M] Department of Genetics, University of North Carolina, Chapel Hill, NC, United States. [Calvo,L] Department of Medical Oncology, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain. [Plazaola,A] Department of Medical Oncology, Onkologikoa, San-Sebastián, Spain. [Arcusa,A] Department of Medical Oncology, Consorci Sanitari de Terrassa, Barcelona, Spain. [Seguí-Palmer,M.A] Department of Medical Oncology, Corporació Sanitària Parc Taulí, Sabadell, Spain. [Ribelles,N, Alba,E] Department of Medical Oncology, Department of Pathology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Rodríguez-Lescure,A] Department of Medical Oncology, Hospital General de Elche, Alicante, Spain. [Guerrero,A] Department of Medical Oncology, Instituto Valenciano de Oncología (IVO), Valencia, Spain. [Ruiz-Borrego,M] Department of Medical Oncology, Hospital Universitario Virgen Del Rocío, Sevilla, Spain. [Munarriz,B] Department of Medical Oncology, Hospital Universitario la Fe, Valencia, Spain. [López,J.A] Department of Medical Oncology, Hospital San Camilo, Madrid, Spain.[Pitcher,B.N] Alliance Statistical and Data Center, Duke University, Durham, NC, United States. [Liu,M.C] Department of Oncology, Mayo Clinic, Rochester, MN, United States. [Citron,M.L] ProHEALTH Care Assoc., LLP, Lake Success, NY, United States. [Ellis,M.J, Mardis,E, Vickery,T] Department of Oncology, Washington University St. Louis, MO, United States. [Hudis,C.A] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States. [Winer,E.P] Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States. [Caballero,R, Carrasco,E, Martín,M] GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain. [Martín,M] Department of Medical Oncology, Instituto de Investigación Sanitaria, Hospital Universitario Gregorio Marañón, Madrid, Spain. [Perou,C.M] Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, United States., This work was supported by funds from the NCI Breast SPORE program Grant No. P50-CA58223-09A1 (CMP), by RO1-CA138255 (CMP), by the Breast Cancer Research Foundation (CMP and MJE), National Cancer Institute (NCI) Strategic Partnering to Evaluate Cancer Signatures Grant No. U01 CA114722-01 (MJE), by the Sociedad Española de Oncología Médica (AP), by FEDER (RETICC-RD12/0036/0051, RD12/0036/0042, RD12/0036/0076, RD12/0036/0070), by Instituto de Salud Carlos III—PI13/01718 (AP), by Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (AP) and by the Alliance Statistics and Data Center (U10-CA33601).
المصدر: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
BRITISH JOURNAL OF CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
British Journal of Cancerمصطلحات موضوعية: Oncology, Cancer Research, Análisis de supervivencia, Colorectal cancer, Triple Negative Breast Neoplasms, Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], chemotherapy, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Cohort Studies, Prostate cancer, 0302 clinical medicine, Clinical trials, Breast cancer, Quimioteràpia, Triple-negative breast cancer, Subtypes, 0303 health sciences, Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Survival Analysis [Medical Subject Headings], subtypes, Genomics, Middle Aged, 3. Good health, Treatment Outcome, Estudi de casos, 030220 oncology & carcinogenesis, Female, Neoadjuvant, Basal like, intrinsic, medicine.medical_specialty, Antineoplastic Agents, basal like, Càncer de mama, 03 medical and health sciences, breast cancer, Internal medicine, genomics, medicine, Humans, Chemotherapy, Lung cancer, Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings], Survival analysis, 030304 developmental biology, Proportional hazards model, business.industry, neoadjuvant, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [Medical Subject Headings], Neoplasias de la mama triple negativas, Antineoplásicos, medicine.disease, Survival Analysis, Expressió gènica, Intrisic, Check Tags::Female [Medical Subject Headings], Intrinsic, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies [Medical Subject Headings], Clinical Study, Gene expression, Case studies, Resultado del tratamiento, Health Care::Health Services Administration::Quality of Health Care::Outcome and Process Assessment (Health Care)::Outcome Assessment (Health Care)::Treatment Outcome [Medical Subject Headings], Skin cancer, business, Assaigs clínics
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::688ea1cdfb20f095a971840b89349431Test
https://ddd.uab.cat/record/185079Test